Navigation Links
INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
Date:10/25/2011

PISCATAWAY, N.J., Oct. 25, 2011 /PRNewswire/ -- INNOPHARMA LLC announced today FDA approval of its Abbreviated New Drug Application (ANDA) for olanzapine injection (the generic equivalent of Zyprexa® injection).

As the developer of this generic injectable drug, INNOPHARMA entered into an agreement with Sandoz Inc., pursuant to which Sandoz will sell, market and distribute the product in the United States.  

About INNOPHARMA:

INNOPHARMA is a sterile product development company, focused on developing niche generic and specialty pharmaceutical products.  Through a business model of internal product development and commercialization licensure, INNOPHARMA has a comprehensive infrastructure for development of injectable and ophthalmic pharmaceutical products at its New Jersey facilities.  INNOPHARMA works with manufacturing and clinical research organizations worldwide for commercialization of its developed products.  More information about INNOPHARMA can be found at www.innopharmallc.com.    

Zyprexa® is a registered trademark of Eli Lilly and Company


'/>"/>
SOURCE INNOPHARMA LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. INNOPHARMA Receives FDA Approval of Generic Levetiracetam Injection
2. INNOPHARMA Receives First FDA Approval
3. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
4. Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial
5. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
6. Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets
7. Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education
8. Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
9. Luminex Corporation Receives Deloitte Technology Fast 500™ Award
10. NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
11. HipSextant™ Navigation System Receives Its First Commercial Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition ... report to their offering. ... The ablation device global market is expected to ... 2023. Ablation is the minimally invasive therapeutic tissue ... or diseased tissue removal, to the removal of abnormally conducting cardiac ...
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... 29, 2017 FinancialBuzz.com News Commentary  ... Data published in a research report by Grand ... a value of USD 55.8 billion by 2025. The projection takes into ... and a more open approach towards cannabis products around the ... Florida , North Dakota , Ohio ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million ... only option for on-premises installation of its Help System for SharePoint was at the ... system into the entire tenant. , The company recently released a modified version ...
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... Rochester, MN (PRWEB) , ... March 28, 2017 ... ... Elastography (MRE), is pleased to be invited to the Siemens Healthineers annual ... imaging professionals. The event will take place from March 27 - 31, ...
(Date:3/28/2017)... ... March 29, 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of ... series titled The Thyroid Secret. Dr. Wentz talked about journey and research recently on ... that medication IS NOT the only solution to deal with thyroid disease. , ...
(Date:3/28/2017)... San Mateo, CA (PRWEB) , ... ... ... Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science ... manuscript leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry ...
Breaking Medicine News(10 mins):